Docosahexaenoic acid is a beneficial replacement treatment for spinocerebellar ataxia 38

OBJECTIVE: Spinocerebellar ataxia 38 (SCA38) is caused by mutations in the ELOVL5 gene, which encodes an elongase involved in the synthesis of polyunsaturated fatty acids, including docosahexaenoic acid (DHA). As a consequence, DHA is significantly reduced in the serum of SCA38 subjects. In the pres...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Ann Neurol
Auteurs principaux: Manes, Marta, Alberici, Antonella, Di Gregorio, Eleonora, Boccone, Loredana, Premi, Enrico, Mitro, Nico, Pasolini, Maria Pia, Pani, Claudia, Paghera, Barbara, Perani, Daniela, Orsi, Laura, Costanzi, Chiara, Ferrero, Marta, Zoppo, Adele, Tempia, Filippo, Caruso, Donatella, Grassi, Mario, Padovani, Alessandro, Brusco, Alfredo, Borroni, Barbara
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2017
Sujets:
Research Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5698802/
https://ncbi.nlm.nih.gov/pubmed/28976605
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.25059
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires